Survival of the fittest glia - Nature Biotechnology

Norge Nyheter Nyheter

Survival of the fittest glia - Nature Biotechnology
Norge Siste Nytt,Norge Overskrifter
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Human glial progenitors transplanted into a chimeric mouse brain replace sick or older human glia, a finding that could one day lead to new treatments for neurological disease.

Neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s and Huntington’s mainly affect the behavior of neurons, but in many cases they are accompanied by defects in the functioning of glial cells.

Using mice with a humanized glial system, the authors show that newly transplanted human glial progenitor cells can outcompete and replace human glial cells affected either by a Huntington’s disease genotype or by aging. Although much future research will be needed, these results raise the tantalizing possibility of glial cell replacement for the treatment of Huntington’s disease, aging and possibly other neurodegenerative diseases.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NatureBiotech /  🏆 231. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Hair loss treatments take aim at the immune system - Nature BiotechnologyHair loss treatments take aim at the immune system - Nature BiotechnologyDrugs commonly used in rheumatology, the JAK inhibitors, are opening up treatment options for people with autoimmune-driven hair loss, and new mechanistic knowledge is also helping scientists tackle androgenic alopecia, the commonest cause of baldness.
Les mer »

Drugs catch a ride through the blood–brain barrier - Nature BiotechnologyDrugs catch a ride through the blood–brain barrier - Nature BiotechnologyA new era of brain-penetrant therapies is opening up, as companies hook up drugs to transferrin receptors or use viral capsids to hitch a ride into previously inaccessible regions.
Les mer »

A genome-wide view of disordered proteins - Nature BiotechnologyA genome-wide view of disordered proteins - Nature BiotechnologyTranscription factors containing disordered regions can now be mapped across the genome, aiding functional studies.
Les mer »

Methodological concerns and lack of evidence for single-synapse RNA-seqMethodological concerns and lack of evidence for single-synapse RNA-seqNature Biotechnology - Methodological concerns and lack of evidence for single-synapse RNA-seq
Les mer »

Reply to: Methodological concerns and lack of evidence for single-synapse RNA-seqReply to: Methodological concerns and lack of evidence for single-synapse RNA-seqNature Biotechnology - Reply to: Methodological concerns and lack of evidence for single-synapse RNA-seq
Les mer »

Making Sense of the Latest IPCC ReportMaking Sense of the Latest IPCC ReportWe humans are killing the physical environment on which human survival depends.
Les mer »



Render Time: 2025-02-28 08:53:25